Introduction
Acetylcholine (ACh) plays an essential role in striatal synaptic plasticity and motor learning, as well as in the pathophysiology of movement disorders Partridge et al., 2002; Pisani et al., 2007) . Striatal ACh innervation is exclusively intrinsic, originating from large cholinergic interneurons (ChIs) (Bolam et al. 1984) . Regardless of their paucity, cholinergic markers measured in this region are among the highest within the brain. ChIs exhibit autonomous pacemaker activity, firing action potentials at rest, providing a constant ACh tone in the striatum (Bennett and Wilson, 1999; Zhou et al., 2002) . Maintenance of discrete ACh levels is ensured by either ACh degrading enzymes or by M 2 /M 4 muscarinic autoreceptors, which exert a negative feedback control on ACh release, hyperpolarizing ChIs through Ca v 2 calcium current inhibition and the opening of potassium (K ϩ ) currents (Yan and Surmeier, 1996; Calabresi et al., 1998) . Five distinct muscarinic acetylcholine receptors (mAChRs; M 1 -M 5 ) have been cloned and divided into two main classes, according to their pharmacological properties and transduction mechanisms (Wess et al., 2007) . Receptor localization studies have revealed a predominant expression of M 1 and M 4 receptors on striatal neuronal subpopulations, whereas M 2 and M 3 are clearly less abundant (Zhang et al., 2002; Zhou et al., 2002) . ACh also exerts its modulatory effects through nicotinic receptors, expressed on striatal dopaminergic terminals whose activation stimulates dopamine release. The close functional interplay between dopamine and nicotinic receptors is proven by the observation that nicotinic receptor antagonists prevent the induction of striatal synaptic plasticity (Partridge et al., 2002) .
High-frequency stimulation (HFS) of the glutamatergic pathway causes either a long-lasting increase, or an enduring decrease in synaptic efficacy, referred to as long-term potentiation (LTP) or long-term depression (LTD), respectively (Calabresi et al., 1992a,b; Lovinger et al., 1993) . Compelling evidence suggests that intrastriatal ACh levels dictate the polarity of plastic changes via M 1 receptor activation, that are expressed on dendrites and spines of medium spiny neurons (MSNs), and are therefore strategically positioned to influence synaptic plasticity (Hersch et al. 1994 , Yan et al., 2001 ). Indeed, M 1 receptor activation increases MSN excitability by reducing KCNQ and Kir2 currents (Galarraga et al., 1999; Shen et al., 2005 Shen et al., , 2007 . Consequently, M 1 receptor activation favors MSN depolarization, playing a permissive role in LTP . However, M 1 receptor activation also inhibits Ca v 1 and Ca v 2 calcium currents (Howe and Surmeier, 1995) that are necessary for LTD induction. It has been proposed recently that reducing ambient M 1 receptor stimulation promotes LTD through disinhibition of Ca v 1 channels (Wang et al., 2006) .
The lack of selective ligands for mAChRs has made it difficult to define the role of striatal mAChRs by pharmacological means (Wess et al., 2007) . We analyzed the consequences of muscarinic autoreceptor loss on striatal synaptic plasticity by using a combined pharmacological/molecular genetic approach. Specifically, we performed electrophysiological recordings from MSNs and ChIs using slices from wild-type (WT), single M 4 Ϫ/Ϫ , or double M 2 /M 4 Ϫ/Ϫ mice (Gomeza et al., 1999a (Gomeza et al., ,b, 2001 ).
Materials and Methods
Slice preparation. All procedures were performed in accord with the European Commission guidelines (86/609/EEC) and approved by the University "Tor Vergata." Mice (4 -6 weeks old) were generated as described (Gomeza et al., 1999a (Gomeza et al., ,b, 2001 . WT littermates of the same mixed genetic background were used as controls. Coronal corticostriatal slices (180 -250 m) were cut in Krebs' solution [containing (in mM) 126 NaCl, 2.5 KCl, 1.3 MgCl 2 , 1.2 NaH 2 PO 4 , 2.4 CaCl 2 , 10 glucose, and 18 NaHCO 3 ], bubbled with 95% O 2 /and 5% CO 2 . Individual slices were transferred in a recording chamber (ϳ0.5-1 ml volume), continuously superfused with oxygenated Krebs' medium at 2.5-3 ml/min (32-33°C).
Electrophysiology. Current-clamp recordings were performed using sharp microelectrodes filled with 2 M KCl (40 -60 M⍀). Signal acquisition and off-line analysis were performed using an Axoclamp 2B amplifier and pClamp9 software (Molecular Devices). Glutamatergic EPSPs were evoked with a bipolar electrode placed in the white matter. Test stimuli were delivered at 0.1 Hz in bicuculline. For highfrequency stimulation (three trains, 3 s duration, 100 Hz frequency, 20 s intervals), stimulus intensity was raised to suprathreshold levels. The amplitude of EPSPs was averaged and plotted as % of the control amplitude for ϳ10 min before HFS. EPSPs did not reveal significant differences in the three groups of mice (data not shown) ( p Ͼ 0.05) and were suppressed by the AMPA receptor antagonist CNQX (10 M).
Whole-cell recordings were made of ChIs visualized by means of infrareddifferential interference contrast videomicroscopy, as described (Bonsi et al., 2007) . Borosilicate glass pipettes (3-5 M⍀) contained (in mM) 125 K ϩ -gluconate, 10 NaCl, 1 CaCl 2 , 2 MgCl 2 , 0.5 BAPTA [1,2-bis (2-aminophenoxy) ethane-N,N,N,N-tetraacetic acid], 19 HEPES, 0.3 GTP, and 1 Mg-ATP, adjusted to pH 7.3 with KOH. Membrane currents were monitored (Axopatch 200B; Molecular Devices) and access resistances measured in voltage clamp were in the range of 5-30 M⍀ before electronic compensation (60 -80% was routinely used). To compare correctly current-voltage relationships before and after drug perfusion, series resistances (8 -15 M⍀) were monitored by the peak amplitude of the capacitive transient induced by a Ϫ5 mV step applied before a voltage ramp (from Ϫ120 to Ϫ40 mV, 6 mV/s). Neurons in which series resistance changed by Ͼ10% were discarded from the statistics. Values given are mean Ϯ SEM. Student's t test and nonparametric Mann-Whitney tests were used to compare means before and after HFS/drug. ANOVA test and post hoc Tukey's test were performed among groups ( p Ͻ 0.05; ␣ ϭ 0.01). Drugs were from Tocris Cookson, except for muscarine, methoctramine, hemicholinium-3, and bicuculline (Sigma), and were applied by switching the control perfusion to drug-containing solution. 
Results

Loss of autoreceptor response in cholinergic interneurons
Large ChIs (n ϭ 61) were identified by means of their peculiar electrophysiological properties (Kawaguchi, 1993; Bonsi et al., 2007) . Intrinsic membrane properties were not significantly different among ChIs from WT mice and M 4 Ϫ/Ϫ or M 2 /M 4 Ϫ/Ϫ mice (ANOVA, p Ͼ 0.05): these interneurons showed depolarized resting membrane potential (RMP; WT, Ϫ56 Ϯ 1.3 mV, n ϭ 10; M 4 Ϫ/Ϫ , Ϫ57 Ϯ 1.7 mV, n ϭ 9; M 2 /M 4 Ϫ/Ϫ , Ϫ53 Ϯ 4.7 mV, n ϭ 6) and high input resistance (WT, 150 Ϯ 3.2 M⍀, n ϭ 10; M4 Ϫ/Ϫ , 144 Ϯ 3.9 M⍀, n ϭ 9; M 2 /M 4 Ϫ/Ϫ , 135 Ϯ 4.4 M⍀, n ϭ 6). More than half of the recorded cells exhibited a spontaneous firing activity. Hyperpolarizing current protocols activated a typical sag in the voltage response, indicative of an I h current (Fig. 1 (Fig. 1 A) .
It has been shown that activation of M 2 /M 4 autoreceptors in ChIs generates a membrane hyperpolarization or an outward current (Calabresi et al., 1998; Pisani et al., 1999) . In the presence of tetrodotoxin (1 M), oxotremorine (300 nM, 3 min) induced an outward current in the recorded cells from WT mice (Fig. 1C) (55 Ϯ 2.6 pA; n ϭ 7) coupled to a decreased conductance (81 Ϯ 3.2% of control; n ϭ 7; p Ͻ 0.05), which was blocked by incubation with the M 2 /M 4 receptorpreferring antagonist methoctramine (300 nM, 10 min). The reversal potential for this outward current was close to the calculated equilibrium potential for K ϩ ions (Fig. 1 D) (Ϫ120 Ϯ 4.0 mV; n ϭ 6). Surprisingly, oxotremorine was still able to induce an outward current in M 4 Ϫ/Ϫ mice ( Fig. 1C) (18 Ϯ 2.6 pA; n ϭ 7). This response was antagonized by methoctramine (Fig. 1C ) and reversed at Ϫ105 Ϯ 2.3 mV (Fig. 1 D) . Conversely, the response to oxotremorine (300 nM) was fully abolished in M 2 /M 4 Ϫ/Ϫ mice ( Fig. 1C) (n ϭ 4). M 1 receptor activation has been shown to depolarize MSNs . Accordingly, perfusion of muscarine (30 M, 1 min) caused a reversible membrane depolarization of MSNs from WT (5.6 Ϯ 3 mV; n ϭ 8) as well as from M 4 Ϫ/Ϫ (5.8 Ϯ 3.5 mV; n ϭ 6) and M 2 /M 4 Ϫ/Ϫ (5.5 Ϯ 4 mV; n ϭ 5) mice that was prevented by the M 1 receptor-preferring antagonist pirenzepine (100 nM) (supplemental Fig. 1 , available at www. jneurosci.org as supplemental material).
Membrane and synaptic responses of MSNs
Knock-out mice lacking striatal mAChRs retain LTP
Removal of magnesium from the perfusing solution reveals an NMDA-mediated component of EPSPs and optimizes LTP induction (Calabresi et al., 1992b) . Accordingly, HFS invariably induced LTP in MSNs from WT mice (Fig. 2 A, B) (180 Ϯ 28% of control, 25 min post-HFS; n ϭ 7; MannWhitney, p ϭ 0.005). Moreover, blocking M 1 receptors with 100 nM pirenzepine prevented LTP in WT MSNs (108 Ϯ 8.8%; n ϭ 6; t test, p ϭ 0.9) (data not shown), confirming that M 1 receptors promote LTP. In M 4 Ϫ/Ϫ or M 2 /M 4 Ϫ/Ϫ mice, HFS induced a LTP of a magnitude similar to that measured in WT littermates (Fig.  2C,D) (M 4 Ϫ/Ϫ , 172 Ϯ 22%, n ϭ 7; M 2 / M 4 Ϫ/Ϫ , 164 Ϯ 17%, n ϭ 5; ANOVA, p Ͼ 0.05). In both knock-out strains, pretreatment with 100 nM pirenzepine did not cause significant changes of basal EPSP, but prevented LTP (data not shown) (n ϭ 3). To verify these data pharmacologically, WT slices were incubated with the M 2 /M 4 receptor antagonist 11
] benzodiazepin-6-one (AF-DX384; 300 nM, 20 min). Under this experimental condition, no significant effect on control EPSP was recorded. Yet, LTP induction was not different from control LTP (Fig. 2 A, B) (172.8 Ϯ 17.2%; n ϭ 6; ANOVA, p ϭ 0.2). Therefore, either genetic or pharmacological blockade of striatal muscarinic autoreceptors failed to alter LTP.
In principle, blockade of LTP by pirenzepine could be a consequence of a facilitatory action on LTD. Thus, in a final set of experiments in M 4 Ϫ/Ϫ mice, slices were treated with sulpiride to block LTD (3 M, 15 min) and then pirenzepine was added (100 nM, 15 min). In this experimental condition, HFS failed to induce LTP both in WT and M 4 Ϫ/Ϫ mice (110.6 Ϯ 13.7%; n ϭ 6; t test, p ϭ 0.38), confirming that M1 receptors are indeed necessary for LTP induction.
Lack of LTD at glutamatergic synapses
Ambient ACh concentrations exert a central role both in LTD or LTP. Loss of striatal muscarinic autoreceptor function is therefore expected to affect LTD by elevating cholinergic tone. HFS caused LTD in MSNs from WT mice (Fig. 3 A, B ) (49.3 Ϯ 11% of control, measured 25 min post-HFS; n ϭ 6; t test, p Ͻ 0.01). Conversely, in MSNs from M 4 Ϫ/Ϫ or M 2 /M 4 Ϫ/Ϫ mice, HFS failed to induce LTD (Fig. 3 A, B ) (M 4 Ϫ/Ϫ , 100.3 Ϯ 8%; M 2 /M 4 Ϫ/Ϫ , 96.6 Ϯ 8%; n ϭ 6 for each strain; t test, p ϭ 0.3). Moreover, in WT slices, pretreatment with the M 2 /M 4 receptor antagonist, AF-DX384 (300 nM, 20 min), fully prevented LTD (data not shown) (103 Ϯ 17%; n ϭ 5, p ϭ 0.62), suggesting that either pharmacological blockade or genetic deletion of muscarinic autoreceptors impairs striatal LTD.
Assuming that this impairment was caused by an increase in striatal ACh release, lowering cholinergic tone is expected to restore LTD. Slices were bathed with hemicholinium-3 (10 M, 20 min), which depletes endogenous ACh (Parikh and Sarter, 2006) . Hemicholinium-3 did not change EPSP amplitude per se, but completely rescued LTD in both M 4 Ϫ/Ϫ and M 2 /M 4 Ϫ/Ϫ mice (Fig. 3C,D) (58.1 Ϯ 13.6% and 53.2 Ϯ 9% of control; n ϭ 6 for M 4 and M 2 /M 4 , respectively; t test, p Ͻ 0.001). Hemicholinium-3 did not cause any change in LTD in MSNs from WT mice (Fig. 3C ) (58 Ϯ 9%; n ϭ 3; p ϭ 0.13).
To verify whether the impairment of LTD involved M 1 receptors, slices were treated with either the non-subtype-selective mAChRs antagonist scopolamine or with the M 1 receptorpreferring antagonist pirenzepine. Both 3 M scopolamine (20 min) and pirenzepine (100 nM, 20 min) did not modify basal EPSP amplitude, but restored LTD (Fig. 4) (scopolamine: 67.3 Ϯ 11.3%, n ϭ 5, Mann-Whitney, p Ͻ 0.0001 for M 4 Ϫ/Ϫ mice; 65 Ϯ 14.4%, n ϭ 5, p Ͻ 0.0001 for M 2 /M 4 Ϫ/Ϫ mice; pirenzepine: 53 Ϯ 10.5%, n ϭ 6, t test p Ͻ 0.0001 for M 4 Ϫ/Ϫ mice; 51.4 Ϯ 9.5%, n ϭ 6, p Ͻ 0.0001 for M 2 /M 4 Ϫ/Ϫ mice; ANOVA among groups, p ϭ 0.7).
"Competition" between LTD and LTP could hypothetically account for the rescue of LTD by pirenzepine. To address this hypothesis, the effects of pirenzepine on LTD were tested also in the presence of d] cyclohepten-5,10-imine maleate; 30 M, 15 min], an NMDA receptor antagonist, to block LTP. In such experimental condition, HFS was still able to restore LTD in M 4 Ϫ/Ϫ mice (48.7 Ϯ 11.6%; n ϭ 5; Mann-Whitney, p Ͻ 0.0001).
Discussion
Maintenance of ACh homeostasis in the striatum is of primary importance for correct motor control . Loss of autoreceptors expressed on striatal ChIs is therefore expected to lead to a tonic increase in ACh levels and altered locomotion. Indeed, the oxotremorine-mediated inhibition of K ϩ -stimulated [ 3 ACh] efflux was completely lost in cortical and striatal tissues from M 2 /M 4 Ϫ/Ϫ mice (Zhang et al., 2002) . Similarly, a large elevation in basal ACh content was found in the hippocampus of either M 2 or M 4 single or M 2 /M 4 double knock-out mice (Tzavara et al., 2003) . Moreover, in behavioral studies, M 4 Ϫ/Ϫ mice displayed increased basal locomotor activity (Gomeza et al., 1999b) .
Consistent with these findings, we found that the outward current recorded in ChIs was mostly reduced in single M 4 Ϫ/Ϫ and abolished in M 2 /M 4 Ϫ/Ϫ mice, implicating both receptors in the cholinergic autoreceptor response. Accordingly, anatomical and pharmacological evidence identified both the M 2 and M 4 subtypes as striatal autoreceptors (Zhang et al., 2002) .
Disruption of the M 2 /M 4 -mediated autoregulatory mechanism has been shown to alter synaptic plasticity in the hippocampus as well as in the visual cortex (Tzavara et al., 2003; Origlia et al., 2006) . We tested the hypothesis that a presumed increase in cholinergic tone would influence striatal synaptic plasticity, providing the first evidence that striatal synaptic plasticity is indeed critically dependent on the levels of endogenous ACh, with mice. In keeping with the assumption that elevated striatal ACh release affected LTD in mice lacking muscarinic autoreceptors, we were able to restore LTD by lowering striatal cholinergic tone with hemicholinium-3, which blocks the highaffinity choline transporters, preventing ACh resynthesis (Parikh and Sarter, 2006) . Reducing M 1 receptor activity has been proposed to facilitate LTD induction (Wang et al., 2006) . Accordingly, we found that blockade of M 1 receptors with pirenzepine was able to fully rescue LTD in both M 4 Ϫ/Ϫ and M 2 /M 4 Ϫ/Ϫ mice. Our data are consistent with the novel concept that bidirectional synaptic plasticity in the striatum is strictly regulated by ACh provided by ChIs. Under physiological conditions, striatal dopamine inhibits the activity of ChIs and ACh release (DeBoer et al., 1996; Pisani et al., 2000; Maurice et al., 2004) . Moreover, different pathophysiological conditions characterized by striatal dopaminergic dysfunction, including Parkinson's disease and dystonia, are accompanied by abnormal cholinergic function Pisani et al., 2007) . Accordingly, mAChRs antagonists are used in the symptomatic treatment of these movement disorders (Lang and Lees, 2002; Horn and Comella, 2007) . The findings reported here may contribute to a better understanding of how alterations in striatal circuitry are linked to motor dysfunction and eventually help identify novel therapeutic strategies to fine tune striatal cholinergic function in human disease.
